drugset / Trial / NCT00834366

A Study to Compare the Relative Bioavailability of Two 200 Mg Tramadol Hydrochloride Tablet Products Under Fasting Conditions

NCT00834366

Phase 1 Completed 26 enrolled Labopharm Inc.
RandomizedCrossoverOpen-label

Summary

To determine whether the test product, Labopharm Tramadol HCl Once-A-Day (OAD) 200 mg film-coated tablets, and the reference product, Labopharm Tramadol HCl OAD 200 mg uncoated tablets, are bioequivalent.

Timeline

Start
2005-02
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 200 mg Oral

Indications

No indication recorded.